Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
RESEARCH TOOLSreports
Holding PTGX?
Track your performance easily
Protagonist Therapeutics (PTGX) Ownership Overview
1.42% Insiders
14.38% Mutual Funds
0.86% Other Institutional Investors
27.86% ETFs
55.48% Public Companies and Individual Investors
The ownership structure of Protagonist Therapeutics (PTGX) stock is a mix of institutional, retail, and individual investors. Approximately 43.10% of the company’s stock is owned by Institutional Investors, 1.42% is owned by Insiders, and 55.48% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 13, 2024 | Asif Ali Cfo | xxxxxxxxxxxxx | $631872 |
| Apr 19, 2024 | Asif Ali Cfo | xxxxxxxxxxxxx | $30986 |
| Mar 01, 2024 | Asif Ali Cfo | xxxxxxxxxxxxx | $764365 |
| Jan 04, 2024 | xxxxxxxxxxxxx | $30012 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $262439 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $19294332 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $28488294 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $43961667 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,087,690 | Institution | 12.03% | 325,324,971 | |
| 5,840,773 | Institution | 9.92% | 268,091,481 | |
| 3,559,714 | Institution | 6.04% | 163,390,873 | |
| 2,583,307 | Institution | 4.39% | 118,573,791 | |
| 1,904,662 | Institution | 3.23% | 87,423,986 | |
| 1,707,209 | Institution | 2.90% | 78,360,893 | |
| 1,268,735 | Institution | 2.15% | 58,234,937 | |
| 931,890 | Institution | 1.58% | 42,773,751 | |
| 909,055 | Institution | 1.54% | 41,725,625 | |
| 822,173 | Institution | 1.40% | 37,737,741 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,583,307 | Institution | 4.39% | 118,573,791 | |
| 909,055 | Institution | 1.54% | 41,725,625 | |
| 663,393 | Institution | 1.13% | 30,449,739 | |
| 621,965 | Institution | 1.06% | 28,548,194 | |
| 461,173 | Institution | 0.78% | 21,167,841 | |
| 425,569 | Institution | 0.72% | 19,533,617 | |
| 423,913 | Institution | 0.72% | 19,457,607 | |
| 296,598 | Institution | 0.50% | 13,613,848 | |
| 259,240 | Institution | 0.44% | 11,899,116 | |
| 245,872 | Institution | 0.42% | 11,285,525 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,755,055 | Institution | 6.37% | 175,586,372 | |
| 1,873,671 | Institution | 3.18% | 84,315,195 | |
| 1,700,617 | Institution | 2.89% | 79,520,851 | |
| 1,499,742 | Institution | 2.55% | 70,127,936 | |
| 966,302 | Institution | 1.64% | 45,184,282 | |
| 875,572 | Institution | 1.49% | 39,400,740 | |
| 517,625 | Institution | 0.88% | 24,204,145 | |
| 520,725 | Institution | 0.88% | 23,901,278 | |
| 452,688 | Institution | 0.77% | 21,167,691 | |
| 406,138 | Institution | 0.69% | 18,991,013 |
FAQ
Who Owns Protagonist Therapeutics (PTGX)?
According to the latest TipRanks data, approximately 0.86% of the company's stock is held by institutional investors, 1.42% is held by insiders, and 55.48% is held by retail investors.
What percentage of Protagonist Therapeutics (PTGX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.86% of Protagonist Therapeutics (PTGX) stock is held by institutional investors.
What percentage of Protagonist Therapeutics (PTGX) stock is held by retail investors?
According to the latest TipRanks data, approximately 55.48% of Protagonist Therapeutics (PTGX) stock is held by retail investors.
Who owns the most shares of Protagonist Therapeutics (PTGX)?
iShares owns the most shares of Protagonist Therapeutics (PTGX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.